PIM3, a member of the PIM kinase family, is significant in regulating T-cell proliferation; inhibiting PIM3 can induce CD4+ T cells to halt in the G0/G1 phase, preventing their proliferation, and PIM3 inhibitors have demonstrated effectiveness in CD4+ T cell-mediated IBD models [79]. Here, CD4 is linked to inflammatory bowel disease.